Another Nigerian, Onyema Ogbuagu, has made the Africa proud as he was part of the doctors that are involved in the breakthrough Pfizer COVID-19 vaccine. BBC reports that Onyeama said that the efficacy of the drug is as real as it was announced. It should be noted that when administered, the result is 94% effective among adults that are 65 years old.
Below is a brief of Dr Oyema Ogbuagu
1. His family background Onyeama is the son of the former vice-chancellor of Abia State University, Nigeria. His mother is a professor of sociology. Not only does he have a twin but unlike him, his brother is an engineer.
2. His first degree in Nigeria: The much-celebrated Nigerian medical official studied medicine at the University of Calabar in Cross River state and graduated in 2003. He did his residency at Mount Sinai School of Medicine and in 2012 had his certification from Internal Medicine.
3. Other professional exploits: In 2015, the Nigerian became a fellow of the American College of Physicians. Two years after, he was nominated for the Charles W Bohmfalk Award in Clinical Science at Yale University School of Medicine. According to TheCable, Ogbuagu was awarded the Gerald H Friedland award for outstanding international research in 2019.
4. Onyema’s current position He is the present Yale head investigator for diverse clinical trials for COVID-19 including Remdesivir that was earlier approved.
Others are leronlimab and remdesivir and tocilizumab combination therapy including the Pfizer/BioNTech Vaccine trial.
5. How long has he been with Yale? According to his short profile on the school’s site, he has been the director of the Yale AIDS Program HIV clinical programme and an investigator of other clinical trials for five years now.